Israeli scientists say Gaucher’s disease drugs may help treat Covid-19
Scientists from the Israeli Institute for Biological Research (IIBR) have claimed that analogues of two...
Read More...
Focus:
Middle-east-and-africa
-
![Neovii]()
TAU and Neovii team up to develop Covid-19 vaccine
Israel-based Tel Aviv University (TAU)’s technology transfer company Ramot has entered a research and licence...
Read More...
-
![Kamada; Kedrion]()
Kamada and Kedrion to develop immunoglobulin product for Covid-19
Biopharmaceutical companies Kamada and Kedrion Biopharma have partnered to develop, manufacture and distribute a human...
Read More...
-
![Coronavirus (2019-nCoV) drugs]()
Coronavirus treatment: Vaccines/drugs in the pipeline for COVID-19
Here are the potential human coronavirus vaccines/drugs pharmaceutical companies across the world are developing following...
Read More...
-
![Top 10 coronavirus countries]()
COVID-19 coronavirus: Top ten most-affected countries
One Asian country and seven European countries are among the ten most affected list of...
Read More...
-
![Israel; vaccine]()
Israeli scientists begin animal testing of Covid-19 vaccine prototype
The Israel Institute for Biological Research (IIBR) has made 'significant' progress in creating a vaccine...
Read More...
-
![]()
COVID-19 in Iran: Coronavirus outbreak, measures and impact
The Islamic Republic of Iran was the first Middle East country to report a death...
Read More...
-
![Covid-19 death toll]()
COVID-19 in the Middle East: Coronavirus-affected countries
Covid-19 is the second coronavirus outbreak that affects the Middle East, following the MERS-CoV reported...
Read More...
-
![kaletra]()
Israel approves import of generic of AbbVie’s HIV drug for Covid-19
Israel health ministry has approved the licensing of a generic version of AbbVie’s HIV drug...
Read More...
-
![SignPath]()
SignPath, Relief explore drugs for Covid-19-related ARDS
SignPath Pharma has started efforts to develop Lipocurc, an intravenous liposomal curcumin formulation, to treat...
Read More...
